At last month's European Association of Nuclear Medicine Congress in Glasgow, Scotland, Dr. Henry Wagner presented preliminary results on the Molecular Coincidence Detection high-energy imaging technique under development by ADAC Laboratories of
At last month's European Association of Nuclear Medicine Congress in Glasgow, Scotland, Dr. Henry Wagner presented preliminary results on the Molecular Coincidence Detection high-energy imaging technique under development by ADAC Laboratories of Milpitas, CA. Wagner, who is a professor of radiation health sciences at John Hopkins Medical Institutions in Baltimore, said MCD could change the way patients with lung cancer are treated.
Wagner is participating in a multicenter clinical trial sponsored by ADAC to demonstrate the clinical effectiveness of MCD in oncology patients whose cancer may have metastasized. ADAC hopes that MCD can help differentiate between benign and malignant nodules, and determine whether surgical treatment is most appropriate.
In Wagner's trials, 35 patients were studied, with MCD producing a 96% sensitivity and an 80% specificity. Results from MCD could enable physicians to identify, prior to surgery, lung cancer patients who have a good chance of surgical cure and those who should be treated instead by radiation or chemotherapy, thus avoiding unnecessary surgery, according to Wagner.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
Systematic Review: PET/MRI May be More Advantageous than PET/CT in Cancer Imaging
July 18th 2024While PET/MRI and PET/CT had comparable sensitivity for patient-level regional nodal metastases and lesion-level recurrence, the authors of a systematic review noted that PET/MRI had significantly higher accuracy in breast cancer and colorectal cancer staging.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Enhanced Mobile CT System with High-Resolution Photon-Counting Technology
July 15th 2024Photon-counting CT-optimized features with the OmniTom Elite system include 30 cm field of view scanning, continuous spiral scanning, and an ultra-high-resolution capability of 0.141 mm resolution.